Ardent Health, Inc. (NYSE: ARDT): Ardent Health, Inc. is being investigated for securities violations in connection with a significant drop in its stock price. BFA is investigating whether Ardent Health violated the federal securities laws by making false and misleading statements to investors. Investors can file a class action lawsuit to potentially recover losses.
If you lost money on your investments in Ardent Health, you are encouraged to submit your information.
Why Is Ardent Health Being Investigated for Securities Violations?
Ardent Health is a provider of healthcare in mid-sized urban communities across the U.S. The Company operates a network of hospitals, ambulatory facilities, and physician practices. During the relevant period, it appears that Ardent Health improperly accounted for its accounts receivable and professional liability reserves.
Why Did Ardent Health’s Stock Drop?
On November 12, 2025, Ardent Health reported its Q3 2025 financial results. The Company revealed it had completed “hindsight evaluations of historical collection trends” that resulted in a $43 million decrease in revenue for the quarter. Ardent Health also revealed that it increased its professional liability reserves by $54 million because of “adverse prior period claim developments” resulting from a set of claims between 2019 and 2022 “as well as consideration of broader industry trends.” On this news, the price of Ardent Health stock dropped over 33% during the course of trading on November 13, 2025.
Contact Us
If you lost money when Ardent Health securities dropped in price, you are encouraged to submit your information using the form on this page to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212.789.3619
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of any class action lawsuit. The firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.
